ISABEL TOLENTINO-MIRASOL: Open Payments
NPI 1255442703 · NORTHPORT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,510 in 136 payments from 13 companies in 2025. Trend: 2023 $2,086 · 2024 $2,582 · 2025 $3,510
Food & beverage: $3,401Education: $109
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $575 |
| Neurocrine BioSciences, Inc. | 29 | $548 |
| E.R. Squibb & Sons, L.L.C. | 17 | $503 |
| Teva Pharmaceuticals USA, Inc. | 20 | $475 |
| Alkermes, Inc. | 16 | $466 |
| Otsuka America Pharmaceutical, Inc. | 15 | $264 |
| Lundbeck LLC | 8 | $217 |
| ABBVIE INC. | 8 | $192 |
| Axsome Therapeutics, Inc. | 3 | $82 |
| Janssen Pharmaceuticals, Inc | 2 | $66 |
Products named: CAPLYTA, INGREZZA, COBENFY, ARISTADA, REXULTI, AUSTEDO XR, ABILIFY MAINTENA, VRAYLAR.
Industry payments across NY — which companies pay providers there.
